Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization
The Journal of Infectious Diseases2008Vol. 197(10), pp. 1419–1426
Citations Over TimeTop 10% of 2008 papers
Chun‐Yi Lu, Yen‐Hsuan Ni, Bor‐Luen Chiang, Pei‐Jer Chen, Mei‐Hwei Chang, Luan‐Yin Chang, Ih‐Jen Su, Hsu‐Sung Kuo, Li‐Min Huang, Ding‐Shinn Chen, Chin‐Yun Lee
Abstract
A notable proportion of fully vaccinated adolescents had lost immune memory conferred by a plasma-derived HB vaccine 15-18 years later. This decay of immune memory may raise concerns about the need for a booster vaccine for high-risk groups in the long run.
Related Papers
- → Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine(2022)15 cited
- → Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2(2022)13 cited
- → Effectiveness and duration of a second COVID-19 vaccine booster(2022)2 cited
- STUDY ON IMMUNORESPONSIBILITY TO BOOSTER INJECTION OF HBV VACCINATION(1993)
- → Protection following BNT162b2 booster substantially exceeds that of a fresh 2-dose vaccine: a quasi-experimental study(2021)